Construction d’une collection de ß-lactamases purifiées d’intérêt clinique (Cß-lactaP)
Nous disposons au sein de notre laboratoire d’une collection d’environ [...]
AXIS 2: Prevent and treat infectious diseases
- Innovative approaches to vaccination
- New therapeutic strategies (human or animal)
- Impact of genetic variability of hosts for their immune defenses against pathogens and responses to vaccination
Axis 2 coordinator
Philippe LOISEAU
Chimiothérapie Antiparasitaire, Université Paris Sud
Jean-Daniel LELIEVRE
Physiopathologie du VIH, Immunologie clinique, APHP
Roger LEGRAND
Infections Virales, Maladies Auto-immunes, CEA
Evelyne JOUVIN-MARCHE
Immunologie, inflammation, infectiologie et microbiologie (I3M), INSERM
Françoise BOTTEREL-CHARTIER
Parasitologie, Mycologie - APHP
Supported projects : "AXIS 2: Prevent and treat infectious diseases"
DIM Axes
AXIS 1:
Anticipate the emergence of human and animal infectious diseases
- Contribution of broad methodologies
- Study of impacts on environmental impacts
- Epidemiological surveillance
AXIS 2:
Prevent and treat infectious diseases
- Innovative approaches to vaccination
- New therapeutic strategies (human or animal)
- Impact of genetic variability of hosts for their immune defenses against pathogens and responses to vaccination
AXIS 3:
Social Perceptions of Infectious Disease Prevention and Innovation
- Impacts of therapeutic and diagnostic innovations
- Transformations of relationships between humans and animals
